ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.

Industry: Pharmaceutical Preparations Peers: Alpha Compute Corp Fusion Pharmaceuticals Inc. Xenon Pharmaceuticals Inc